FP-C TEST REVIEW PRACTICE EXAMINATION 2026
QUESTIONS WITH ANSWERS GRADED A+
● Neurological Critical Care. Answer: Managing brain and spinal cord emergencies in
transport
● Stroke Protocols. Answer: Time-sensitive systems for rapid stroke identification and
treatment
● Stroke Alert. Answer: Activation of stroke team and imaging suite for suspected stroke
● tPA Eligibility. Answer: Criteria including time window and contraindications for
thrombolysis
● Mechanical Thrombectomy. Answer: Catheter-based clot removal for large vessel
occlusion stroke
● Hemorrhagic Stroke Management. Answer: Controlling blood pressure and reversing
anticoagulation
● Subarachnoid Hemorrhage. Answer: Bleeding into subarachnoid space typically from
aneurysm rupture
● Vasospasm. Answer: Arterial narrowing following subarachnoid hemorrhage causing
ischemia
● Nimodipine. Answer: Calcium channel blocker preventing vasospasm after SAH
● Hydrocephalus. Answer: Excess CSF accumulation requiring drainage in stroke and TBI
● EVD. Answer: External ventricular drain removing CSF and monitoring ICP
● ICP Monitoring. Answer: Continuous measurement of intracranial pressure
● CPP Target. Answer: Cerebral perfusion pressure target of 60-70 mmHg in TBI
● Hypertonic Saline Use in TBI. Answer: Reduces ICP by drawing fluid from brain tissue
● Hyperventilation in TBI. Answer: Temporary measure reducing CO2 and ICP in herniation
, ● Sedation in TBI. Answer: Propofol or midazolam reducing metabolic demand and ICP
● Neuromuscular Blockade. Answer: Paralytics reducing muscle activity and ICP elevation
● Barbiturate Coma. Answer: Pentobarbital reducing metabolic demand in refractory ICP
elevation
● Decompressive Craniectomy. Answer: Removing skull portion to relieve uncontrolled ICP
● Spinal Cord Injury. Answer: Damage to spinal cord causing motor or sensory deficit
● Complete SCI. Answer: Total loss of motor and sensory function below injury level
● Incomplete SCI. Answer: Partial preservation of motor or sensory function below injury
level
● Neurogenic Shock. Answer: Hypotension and bradycardia from loss of sympathetic tone
in SCI
● Autonomic Dysreflexia. Answer: Dangerous BP elevation triggered by stimulus below SCI
level
● Methylprednisolone in SCI. Answer: Controversial steroid use in acute SCI
● Seizure Management in Transport. Answer: Benzodiazepines as first-line treatment
● Lorazepam. Answer: Benzodiazepine for acute seizure management
● Diazepam. Answer: Rectal or IV benzodiazepine for seizure management
● Midazolam. Answer: Intranasal or IM benzodiazepine for prehospital seizure
● Levetiracetam. Answer: Second-line antiepileptic for status epilepticus
● Fosphenytoin. Answer: IV antiepileptic as second-line for status epilepticus
● Phenobarbital. Answer: Third-line antiepileptic for refractory status epilepticus
● Propofol for Seizure. Answer: Anesthetic used for refractory status epilepticus
● Ketamine for Seizure. Answer: NMDA antagonist used for refractory status epilepticus
● Sepsis in Critical Transport. Answer: Managing infection with organ dysfunction during
transport
QUESTIONS WITH ANSWERS GRADED A+
● Neurological Critical Care. Answer: Managing brain and spinal cord emergencies in
transport
● Stroke Protocols. Answer: Time-sensitive systems for rapid stroke identification and
treatment
● Stroke Alert. Answer: Activation of stroke team and imaging suite for suspected stroke
● tPA Eligibility. Answer: Criteria including time window and contraindications for
thrombolysis
● Mechanical Thrombectomy. Answer: Catheter-based clot removal for large vessel
occlusion stroke
● Hemorrhagic Stroke Management. Answer: Controlling blood pressure and reversing
anticoagulation
● Subarachnoid Hemorrhage. Answer: Bleeding into subarachnoid space typically from
aneurysm rupture
● Vasospasm. Answer: Arterial narrowing following subarachnoid hemorrhage causing
ischemia
● Nimodipine. Answer: Calcium channel blocker preventing vasospasm after SAH
● Hydrocephalus. Answer: Excess CSF accumulation requiring drainage in stroke and TBI
● EVD. Answer: External ventricular drain removing CSF and monitoring ICP
● ICP Monitoring. Answer: Continuous measurement of intracranial pressure
● CPP Target. Answer: Cerebral perfusion pressure target of 60-70 mmHg in TBI
● Hypertonic Saline Use in TBI. Answer: Reduces ICP by drawing fluid from brain tissue
● Hyperventilation in TBI. Answer: Temporary measure reducing CO2 and ICP in herniation
, ● Sedation in TBI. Answer: Propofol or midazolam reducing metabolic demand and ICP
● Neuromuscular Blockade. Answer: Paralytics reducing muscle activity and ICP elevation
● Barbiturate Coma. Answer: Pentobarbital reducing metabolic demand in refractory ICP
elevation
● Decompressive Craniectomy. Answer: Removing skull portion to relieve uncontrolled ICP
● Spinal Cord Injury. Answer: Damage to spinal cord causing motor or sensory deficit
● Complete SCI. Answer: Total loss of motor and sensory function below injury level
● Incomplete SCI. Answer: Partial preservation of motor or sensory function below injury
level
● Neurogenic Shock. Answer: Hypotension and bradycardia from loss of sympathetic tone
in SCI
● Autonomic Dysreflexia. Answer: Dangerous BP elevation triggered by stimulus below SCI
level
● Methylprednisolone in SCI. Answer: Controversial steroid use in acute SCI
● Seizure Management in Transport. Answer: Benzodiazepines as first-line treatment
● Lorazepam. Answer: Benzodiazepine for acute seizure management
● Diazepam. Answer: Rectal or IV benzodiazepine for seizure management
● Midazolam. Answer: Intranasal or IM benzodiazepine for prehospital seizure
● Levetiracetam. Answer: Second-line antiepileptic for status epilepticus
● Fosphenytoin. Answer: IV antiepileptic as second-line for status epilepticus
● Phenobarbital. Answer: Third-line antiepileptic for refractory status epilepticus
● Propofol for Seizure. Answer: Anesthetic used for refractory status epilepticus
● Ketamine for Seizure. Answer: NMDA antagonist used for refractory status epilepticus
● Sepsis in Critical Transport. Answer: Managing infection with organ dysfunction during
transport
